Rare causes of pulmonary hypertension in infants

Česká verzia

Authors: Genzor Martin; Kováčiková Ubica; Škrak Peter
Authors place of work: Oddelenie anestéziológie a intenzívnej medicíny, Detské kardiocentrum, NUSCH a. s., Bratislava, Slovenská republika
Published in the journal: Čes-slov Pediat 2024; 79 (6): 323-328.
Category: Case Report
doi: https://doi.org/10.55095/CSPediatrie2024/039

Summary

Pulmonary hypertension is a serious disease leading to right-sided heart failure. Although the incidence of pulmonary hypertension associated with congenital heart diseases is decreasing, the incidence of pulmonary hypertension associated with other non-cardiac diseases has an increasing trend. We provide three case reports of patients with noncardiac causes of pulmonary hypertension who were hospitalized in the Pediatric Cardiac Center, a newborn with tricuspid valve dysplasia and thyreotoxicosis, a newborn with congenital pulmonary lymphangiectasis treated with extracorporeal oxygenation, and an infant with alveolar capillary dysplasia with misalignment of pulmonary veins. Pulmonary hypertension is diagnosed based on echocardiography followed by a detailed differential diagnostic workup. In addition to the symptomatic treatment of pulmonary hypertension, patient management also focuses on the treatment of underlying diseases.

Keywords:

Pulmonary hypertension – neonatal thyrotoxicosis – alveolar capillary dysplasia – congenital pulmonary lymphangiectasia

Zdroje

1. Kovačiková Ľ. et al. Intenzívna starostlivosť v detskej kardiológii. Bratislava: Solen 2022: 135–149, 359–381.

2. Abman SH, Mullen MP, Sleeper LA, et al. Pediatric Pulmonary Hypertension Network. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. Eur Resp J 2022; 59: 2003337.

3. Cerro MJ, Abman S, Diaz G, et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011. Pulm Circ 2011; 1(2): 286–298.

4. Obeid R, Kalra VK, Arora P, et al. Neonatal thyrotoxicosis presenting as persistent pulmonary hypertension. Case Reports 2012; 2012: bcr0220125939.

5. Oden J, Cheifetz IM. Neonatal thyrotoxicosis and persistent pulmonary hypertension necessitating extracorporeal life support. Pediatrics 2005; 115(1): e105–8.

6. Marvisi M, Balzarini L, Mancini C, et al. Thyroid gland and pulmonary hypertension. What‘s the link? Panminerva Med 2013; 55(1): 93–7.

7. Guarnieri GF, Laforgia N, Mautone A, et al. Delayed closure of ductus arteriosus in term newborns with congenital hypothyroidism: effect of L-thyroxine therapy. Pediatr Cardiol 2008; 29: 455–456.

8. Kwan R, Vasanwala RF, Baral VR. Patent ductus arteriosus in a late preterm neonate: think congenital hypopituitarism. BMJ Case Rep 2022; 15(8): e248188.

9. Reiterer F, Grossauer K, Morris N, et al. Congenital pulmonary lymphangiectasis. Paediatr Respir Rev 2014; 15(3): 275–80.

10. Toru HS, Sanhal CY, Yilmaz GT, et al. Rare congenital pulmonary malformation with diagnostic challenging: congenital pulmonary lymphangiectasia, report of four autopsy cases and review of literature. J Matern Fetal Neonatal Med 2015; 28(12): 1457–60.

11. Resch B, Sever Yildiz G, Reiterer F. Congenital chylothorax of the newborn: a systematic analysis of published cases between 1990 and 2018. Respiration 2022; 101(1): 84–96.

12. Itkin M. Interventional treatment of pulmonary lymphatic anomalies. Tech Vasc Interv Radiol 2016; 19(4): 299–304.

13. Zufferey F, Martinet D, Osterheld MC, et al. 16q24.1 microdeletion in a premature newborn: usefulness of array-based comparative genomic hybridization in persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 2011; 12(6): e427–32.

14. Shaw-Smith C. Genetic factors in esophageal atresia, tracheo-esophageal fistula and the VACTERL association: roles for FOXF1 and the 16q24.1 FOX transcription factor gene cluster, and review of the literature. Eur J Med Genet 2010; 53(1): 6–13.

15. Towe CT, White FV, Grady RM, et al. Infants with atypical presentations of alveolar capillary dysplasia with misalignment of the pulmonary veins who underwent bilateral lung transplantation. J Pediatr 2018; 194: 158–164.e1.

16. Bishop NB, Stankiewicz P, Steinhorn RH. Alveolar capillary dysplasia. Am J Respir Crit Care Med 2011; 184(2): 172–9.

17. Ito Y, Akimoto T, Cho K, et al. A late presenter and long-term survivor of alveolar capillary dysplasia with misalignment of the pulmonary veins. Eur J Pediatr 2015;174, 1123–1126.

18. Lammers AE, Apitz C, Michel-Behnke I, et al. A guide to echocardiographic assessment in children and adolescents with pulmonary hypertension. Cardiovasc Diagn Ther 2021; 11(4): 1160–1177.

19. Kovacikova L, Zahorec M, Nosal M. Sildenafil as a pulmonary vasodilator after repair of congenital heart disease. Bratisl Lek Listy 2007; 108: 453–4.